Status:
COMPLETED
Nalbuphine as an Adjuvant to Local Anaesthetic Mixture in Peribulbar Cataract Surgery
Lead Sponsor:
Cairo University
Collaborating Sponsors:
Mohamed, Ahmed A., M.D.
Nadia Yossif Helmy
Conditions:
Nalbuphine as an Adjuvant to L. A in Peribulbar Block for Cataract Surgery
Eligibility:
All Genders
40-60 years
Phase:
NA
Brief Summary
Nalbuphine has been used as an adjuvant to bupivacaine in intrathecal, epidural, caudal anesthesia and peripheral nerve blocks showing an increase in the efficacy and the duration of postoperative ana...
Detailed Description
44 patients (22 in each group) scheduled for elective cataract surgery using peribulbar block. Patients of Group N received local anesthetics received 6 ml of 0.5% bupivacaine 1 ml hyaluronidase (75 I...
Eligibility Criteria
Inclusion
- patients aged 40-60 years.
- both sex.
- ASA physical status Ι\&II.
- Patient with axial globe length below 26
Exclusion
- Refusal of the patient to participate in the study.
- Coagulation abnormalities(INR\>1.4).
- More than ASA II.
- High myopia with axial length more than 26 mm.
- Mentally retarded patients and failure of proper communication as in deafness .
- Morbidly obese patients(BMI\>35)
- Patients with glaucoma (increased IOP\>20mmgh)
- Patients with history of hypersensitivity to study drugs
Key Trial Info
Start Date :
January 14 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03436836
Start Date
January 14 2018
End Date
February 28 2018
Last Update
May 30 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmed Abdalla Mohamed
Cairo, Egypt, 11451
2
Ahmed Abdalla
Cairo, Egypt, 11451